GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Faes Farma SA (XMAD:FAE) » Definitions » Additional Paid-In Capital

Faes Farma (XMAD:FAE) Additional Paid-In Capital : €1.5 Mil(As of Jun. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Faes Farma Additional Paid-In Capital?


Faes Farma's quarterly additional paid-in capital declined from Dec. 2022 (€1.5 Mil) to Mar. 2023 (€0.0 Mil) but then increased from Mar. 2023 (€0.0 Mil) to Jun. 2023 (€1.5 Mil).

Faes Farma's annual additional paid-in capital stayed the same from Dec. 2021 (€1.5 Mil) to Dec. 2022 (€1.5 Mil) and stayed the same from Dec. 2022 (€1.5 Mil) to Dec. 2023 (€1.5 Mil).

Faes Farma Additional Paid-In Capital Historical Data

The historical data trend for Faes Farma's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Faes Farma Additional Paid-In Capital Chart

Faes Farma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.46 1.46 1.46 1.46 1.46

Faes Farma Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.46 - 1.46 1.46

Faes Farma Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Faes Farma Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Faes Farma's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Faes Farma (XMAD:FAE) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Faes Farma SA (XMAD:FAE) » Definitions » Additional Paid-In Capital
Comparable Companies
XMAD:ALM XMAD:RJF XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ NBIX SZSE:000538 NSE:DIVISLAB BOM:532321 TSE:4507 HKSE:03692 VTRS TSE:4523 BOM:500124 XPAR:IPN NSE:TORNTPHARM
Traded in Other Exchanges
0K9H:UK FFEA:Germany
Address
Maximo Aguirre, 14, Leioa, Vizcaya, ESP, 48940
Website
http://www.faes.es
Faes Farma SA is a pharmaceutical company that specializes in the research, production, distribution, and sale of prescription and generic drugs, over-the-counter medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The company develops new drugs for the treatment of allergy, venous insufficiency, and irritable bowel syndrome. It also provides animal nutrition products. Faes Farma exports its products to more than 60 countries and has operations in Spain, Portugal, Chile, and Mexico, among others.

Faes Farma (XMAD:FAE) Headlines

No Headlines